Related Experiment Video
Updated: Aug 11, 2026

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
Adenohypophyseal function in bitches treated with medroxyprogesterone acetate
N J Beijerink1, S F M Bhatti, A C Okkens
1Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands. N.J.Beijerink@vet.uu.nl
Medroxyprogesterone acetate (MPA) treatment in female dogs suppressed estrus and ovulation. While it increased FSH and IGF-1, MPA suppressed the adrenal axis and did not affect LH, prolactin, or alpha-MSH secretion.
Area of Science:
- Veterinary Endocrinology
- Reproductive Physiology
- Canine Health
Background:
- Medroxyprogesterone acetate (MPA) is a synthetic progestin used for reproductive control.
- Its effects on the canine adenohypophyseal axis require detailed investigation.
Purpose of the Study:
- To evaluate the impact of chronic MPA administration on the function of the canine adenohypophysis.
- To assess the secretion of key pituitary hormones and their responses to hypothalamic stimulation.
Main Methods:
- Five Beagle bitches received MPA (10mg/kg, every 4 weeks) for 11 months.
- A combined adenohypophyseal function test was performed, administering CRH, GHRH, GnRH, and TRH.
- Plasma hormone levels (ACTH, cortisol, GH, IGF-1, LH, FSH, prolactin, alpha-MSH, TSH) were measured before and during MPA treatment.
Main Results:
- MPA successfully prevented estrus and ovulation.
- Significant increases in FSH and IGF-1 were observed, alongside suppression of the hypothalamic-pituitary-adrenocortical axis (decreased cortisol response).
- LH secretion remained unaffected, while prolactin and alpha-MSH were unchanged; TSH showed a slight increase.
Conclusions:
- Chronic MPA treatment in dogs alters adenohypophyseal function, notably increasing FSH and IGF-1 secretion.
- MPA effectively suppresses reproductive cycles and the adrenal axis while maintaining LH, prolactin, and alpha-MSH levels.
- These findings provide insights into the endocrine effects of MPA in canines.
Related Concept Videos
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Ovarian Cycle
Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
Hormones of the Pituitary Gland
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.

